• database DOAJ indexed

United Kingdom · Taylor & Francis Group

visibility_off Double blind peer review lock_open Open Access · DOAJ

Clinical Lipidology

Clinical Lipidology is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine with an H index of . It is an CC BY-NC Journal with a Double blind peer review review system, and It has a price of 847 €. The scope of the journal is focused on lipidology, cardiovascular diseases, lipid-related disorders, lipids, obesity. It is published in English.

ISSN: 1758-4299

Publisher: Taylor & Francis Group

Category: Endocrinology, Diabetes and Metabolism

Indexation: verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

NPD

H-index NPD

Acceptance rate pie_chart

NPD

Source NPD

Time to publication hourglass_top

7 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

847 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

DOAJ

SJR Impact

—

H-index

—

Docs (year)

—

Docs 3y

—

Total refs

—

Cites 3y

—

Citable 3y

—

Cites/Doc 2y

—

Ref/Doc

—

Immediate OA

847 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Combination therapy with rosuvastatin and fenofibric acid for mixed dyslipidemia: overview of efficacy and safety

Will new statin guidelines lead to overtreatment?

Extended-release niacin and laropiprant in the management of dyslipidemias

Effects of glucocorticoids on fat mass and the therapeutic potential of targeting 11beta-hydroxysteroid dehydrogenase type 1 in obesity

Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia

Effect of infection on lipid profile: focus on Epstein-Barr virus

Dual roles of polyunsaturated fatty acids in retinal physiology and pathophysiology associated with retinal degeneration

Do adipokines link obesity to its related metabolic and cardiovascular diseases?

Diet and lifestyle interventions on lipids: combination with genomics and metabolomics

Diagnosis and management of lipodystrophy: a practical update

Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?

Conjugated linoleic acids and inflammation: isomer- and tissue-specific responses

SHOW MORE ARTICLES

Combined therapy with Xuezhikang and low-dose rosuvastatin provides an effective and safe therapeutic strategy for dyslipidemic patients

50th International Conference on the Bioscience of Lipids

Cholesterol removal from plaques and elimination from the body: change in paradigm to reduce risk for heart disease

Cardiovascular risk in pediatric nonalcoholic fatty liver disease: recent advances

Cardiovascular complications in familial combined hyperlipidemia: beyond the atherogenic dyslipidemia

Biohumoral and comorbidity determinants of low HDL-C during acute phase response in a setting of in-hospital patients

Atorvastatin: a review of its pharmacological properties and use in familial hypercholesterolemia

Atherogenesis and aggregated electronegative LDL

Assessment of thyroid hormones status and some adipocytokines among Egyptian obese children

An update on testosterone, HDL and cardiovascular risk in men

Afamin is a promising novel marker for metabolic syndrome and related diseases

Adipose tissue, inflammation and atherosclerosis

FAQs

SJR is not available (NPD) for Clinical Lipidology in the CountryOfPapers database.

Immediate OA APC is 847 EUR.